BHVN Q3 2022 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$68M

Net Income

-$69M

EPS (Diluted)

$-1.75

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$100M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$136M

Total Liabilities

$35M

Stockholders' Equity

$100M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$68M	-$55M	-21.9%
Net Income	-$69M	-$54M	-26.6%